Embryonic ApS: Financial statements 2025
CVR: 39913739
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
Embryonic ApS (CVR 39913739) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 0 and a net result of DKK 0 compared with DKK 0 the year before. Equity in the 2025 report amounted to DKK 50,000. The solvency ratio was 41.7%.
- Gross Profit
- DKK 0
- Profit/Loss
- DKK 0
- Equity
- DKK 50,000
- Total Assets
- DKK 120,000
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | 0 | 0 | 50 t. | 0 |
| 2024 | - | 0 | 0 | 50 t. | 0 |
| 2023 | 0 | 0 | 0 | 50 t. | - |
| 2022 | - | - | 0 | 50 t. | - |
| 2021 | - | - | 0 | 70 t. | - |
Official annual report
How creditworthy is Embryonic ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
Embryonic ApS has published its annual report for 2024. Gross profit came to DKK 0, and the net result was DKK 0.
About Embryonic ApS
Embryonic ApS is a Danish company of the type Anpartsselskab based in Hesselager, founded in 2018. The company is registered under the industry Ikke-finansielle holdingselskaber. The management consists of Jens Brandt Nellegaard. The board consists of Jens Brandt Nellegaard (chair). The company is owned by Jens Brandt Nellegaard. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK 0 and a net result of DKK 0 compared with DKK 0 the year before. Equity in the 2025 report amounted to DKK 50,000.